Vital safety information for pregnant women who are using or considering using valproate medications for Migraine prevention was released by the FDA today. The results of studies have now provided enough strong evidence that exposure to valproate medications while the mother is pregnant results in decreased IQ scores. This has resulted in the FDA changing the pregnancy category of these drugs from D to X, which means that the risk of use during pregnancy outweighs any possible benefits.

Valpr...